Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epidermal Immunity and Function: Origin in Neonatal Skin. | Front Mol Biosci | 2022 | 35755808 | PubTator, text mining | PubMed |
| Structural and Functional Validation of a Full-Thickness Self-Assembled Skin Equivalent for Disease Modeling. | Pharmaceutics | 2022 | 35745784 | PubTator, text mining | PubMed |
| Antipsoriatic Potential of Quebecol and Its Derivatives. | Pharmaceutics | 2022 | 35745702 | PubTator, text mining | PubMed |
| Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies. | Pathogens | 2022 | 35745496 | PubTator, text mining | PubMed |
| Atopic Dermatitis: Sailing beyond the Sunset with a Multitude of Novel Treatments. | J Clin Med | 2022 | 35743543 | PubTator, text mining | PubMed |
| Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study. | J Clin Med | 2022 | 35743415 | PubTator, text mining | PubMed |
| Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis. | Int J Mol Sci | 2022 | 35743125 | PubTator, text mining | PubMed |
| Role and Function of Mesenchymal Stem Cells on Fibroblast in Cutaneous Wound Healing. | Biomedicines | 2022 | 35740413 | PubTator, text mining | PubMed |
| Skin Care Product Rich in Antioxidants and Anti-Inflammatory Natural Compounds Reduces Itching and Inflammation in the Skin of Atopic Dermatitis Patients. | Antioxidants (Basel) | 2022 | 35739968 | PubTator, text mining | PubMed |
| Exosomes from human induced pluripotent stem cells-derived keratinocytes accelerate burn wound healing through miR-762 mediated promotion of keratinocytes and endothelial cells migration. | J Nanobiotechnology | 2022 | 35729564 | PubTator, text mining | PubMed |
Study on the intervention effect and mechanism of bacillus Calmette-Guerin polysaccharide and nucleic acid injection on atopic dermatitis by targeting the transient receptor potential vanilloid subtype 1 pathway. | Ann Transl Med | 2022 | 35722408 | PubTator, text mining | PubMed |
| The bioactive potential of phytohormones: A review. | Biotechnol Rep (Amst) | 2022 | 35719852 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Uncover Key Regulators of Skin Regeneration in Human Long-Term Mechanical Stretch-Mediated Expansion Therapy. | Front Cell Dev Biol | 2022 | 35712657 | PubTator, text mining | PubMed |
| Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. | Front Genet | 2022 | 35711943 | PubTator, text mining | PubMed |
| Identification of Biomarkers Associated With CD4+ T-Cell Infiltration With Gene Coexpression Network in Dermatomyositis. | Front Immunol | 2022 | 35711463 | PubTator, text mining | PubMed |
| The 1q21.3 region driver gene EFNA3 promotes disease progression via inhibition of lung adenocarcinoma cell apoptosis. | Transl Cancer Res | 2022 | 35706812 | PubTator, text mining | PubMed |
| Managing Atopic Dermatitis with Lebrikizumab - The Evidence to Date. | Clin Cosmet Investig Dermatol | 2022 | 35702658 | PubTator, text mining | PubMed |
Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP). | Ital J Pediatr | 2022 | 35701810 | PubTator, text mining | PubMed |
| Inhibitory Effects of Donkey Hide Gelatin on DNCB-Induced Atopic Dermatitis in NC/Nga Mice. | Front Pharmacol | 2022 | 35694270 | PubTator, text mining | PubMed |
| In situ scarless skin healing of a severe human burn wound induced by a hCTLA4Ig gene-transferred porcine skin graft. | Int J Med Sci | 2022 | 35693752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=29